ZUTRIPRO
Peakchlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride
NDAORALSOLUTION
Approved
Jun 2011
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ZUTRIPRO is a fixed-dose combination oral solution containing chlorpheniramine maleate (antihistamine), hydrocodone bitartrate (opioid), and pseudoephedrine hydrochloride (decongestant). It is indicated for symptomatic relief of cough and congestion associated with upper respiratory conditions. The combination targets multiple symptom pathways: antihistamine suppresses histamine-mediated symptoms, hydrocodone acts as a cough suppressant, and pseudoephedrine provides nasal decongestant effects.
Peak
Product is at peak lifecycle stage with moderate competitive pressure (30%), suggesting stable revenue but limited expansion opportunity for commercial teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ZUTRIPRO offers limited career growth given zero linked job openings and peak lifecycle stage with no clinical expansion activity. Positions supporting this product focus on maintaining market share and managing controlled-substance compliance rather than innovation or launch-phase excitement.
Brand ManagerField Sales Representative
Worked on ZUTRIPRO at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.